0.20
price down icon8.72%   -0.0191
after-market 시간 외 거래: .20
loading
전일 마감가:
$0.2191
열려 있는:
$0.219
하루 거래량:
18.65M
Relative Volume:
0.36
시가총액:
$19.86M
수익:
-
순이익/손실:
$-21.91M
주가수익비율:
-0.1342
EPS:
-1.49
순현금흐름:
-
1주 성능:
-3.89%
1개월 성능:
-8.13%
6개월 성능:
-88.10%
1년 성능:
-94.29%
1일 변동 폭
Value
$0.1978
$0.219
1주일 범위
Value
$0.1978
$0.2394
52주 변동 폭
Value
$0.08
$3.51

Incannex Healthcare Inc Stock (IXHL) Company Profile

Name
명칭
Incannex Healthcare Inc
Name
전화
61 409 840 786
Name
주소
8 CENTURY CIRCUIT, NORWEST NSW
Name
직원
9
Name
트위터
Name
다음 수익 날짜
Name
최신 SEC 제출 서류
Name
IXHL's Discussions on Twitter

IXHL을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Drug Manufacturers - Specialty & Generic icon
IXHL
Incannex Healthcare Inc
0.20 19.86M 0 -21.91M 0 -1.49
Drug Manufacturers - Specialty & Generic icon
RGC
Regencell Bioscience Holdings Ltd
23.70 303.95B 0 -5.87M -767.30K -0.45
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
157.34 74.39B 9.29B 2.52B 2.28B 5.57
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
10.49 48.97B 14.35B 1.85B 0 0.4023
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.72 47.39B 30.08B 710.16M 4.45B 0.2182
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
16.97 20.17B 16.54B -1.64B 749.00M -1.45

Incannex Healthcare Inc 주식(IXHL)의 최신 뉴스

pulisher
Jun 18, 2025

Incannex Flat on Looking Ahead to Clinical Trial - Baystreet.ca

Jun 18, 2025
pulisher
Jun 18, 2025

Incannex Achieves Milestone in Sleep Apnea Drug Trial - TipRanks

Jun 18, 2025
pulisher
Jun 18, 2025

Incannex completes database lock for sleep apnea drug trial - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Incannex achieves key milestone with database lock for RePOSA Phase 2 trial of IHL-42X - TradingView

Jun 18, 2025
pulisher
Jun 18, 2025

Incannex forms joint venture with Mind Medicine Australia for clinic By Investing.com - Investing.com India

Jun 18, 2025
pulisher
Jun 17, 2025

Incannex forms joint venture with Mind Medicine Australia for clinic - Investing.com

Jun 17, 2025
pulisher
Jun 17, 2025

Incannex Healthcare Announces Psychedelic Therapies Joint Venture - TipRanks

Jun 17, 2025
pulisher
Jun 17, 2025

Incannex Healthcare Forms Joint Venture With Mind Medicine Australia To Expand Access To Psychedelic-Assisted Therapy - MarketScreener

Jun 17, 2025
pulisher
Jun 17, 2025

Incannex Healthcare Forms Joint Venture with Mind Medicine Australia to Expand Access to Psychedelic-Assisted Therapy - The Manila Times

Jun 17, 2025
pulisher
Jun 17, 2025

Incannex Healthcare Inc. Forms Joint Venture with Mind Medicine Australia for Psychedelic-Assisted Therapy Clinic in Melbourne - Nasdaq

Jun 17, 2025
pulisher
Jun 17, 2025

Groundbreaking Partnership: Incannex and Mind Medicine Launch Australia's Largest Psychedelic Therapy Center - Stock Titan

Jun 17, 2025
pulisher
Jun 13, 2025

Incannex Healthcare Seeks Nasdaq Transfer to Meet Listing Rules By Investing.com - Investing.com Canada

Jun 13, 2025
pulisher
Jun 13, 2025

Incannex Healthcare Seeks Nasdaq Transfer to Meet Listing Rules - Investing.com

Jun 13, 2025
pulisher
Jun 13, 2025

Incannex Healthcare Transfers Listing to Nasdaq Capital Market - TipRanks

Jun 13, 2025
pulisher
Jun 12, 2025

Incannex Healthcare Cancels Series A Warrants - TipRanks

Jun 12, 2025
pulisher
Jun 12, 2025

Incannex Healthcare Cancels All Outstanding Series A Warrants Following Strategic ATM Execution - The Manila Times

Jun 12, 2025
pulisher
Jun 12, 2025

Incannex Cancels All Warrants, Removes 347M Share Dilution Before Critical Sleep Apnea Trial Data - Stock Titan

Jun 12, 2025
pulisher
Jun 06, 2025

Incannex Healthcare Inc. Provides Clinical Program Update on IHL-42X, an Oral Once-Daily Treatment for Obstructive Sleep Apnea (OSA) - Revista ADVFN

Jun 06, 2025
pulisher
Jun 06, 2025

Incannex Healthcare Inc. Reports Fiscal Third Quarter 2025 Financial Results and Business Updates - mx.advfn.com

Jun 06, 2025
pulisher
Jun 06, 2025

Incannex Healthcare Inc. Advances IHL-42X RePOSA Trial to Phase 3 Following FDA Protocol Clearance - mx.advfn.com

Jun 06, 2025
pulisher
Jun 04, 2025

Incannex Healthcare Inc. Announces Pricing of $12.5 Million Private Placement Priced at the Market Under Nasdaq Rules - mx.advfn.com

Jun 04, 2025
pulisher
Jun 03, 2025

Incannex Expands Advisory Board for OSA Program - TipRanks

Jun 03, 2025
pulisher
Jun 03, 2025

Incannex Healthcare Inc. Appoints Four Experts to IHL-42X Obstructive Sleep Apnea Clinical Advisory Board - Nasdaq

Jun 03, 2025
pulisher
Jun 03, 2025

Harvard and Emory Leaders Join Incannex's Sleep Apnea Program Ahead of Critical Phase 2 Data - Stock Titan

Jun 03, 2025
pulisher
May 31, 2025

Cannabis Stocks To Add to Your Watchlist – May 29th - Defense World

May 31, 2025
pulisher
May 30, 2025

Incannex advances to phase 3 trial for sleep apnea treatment By Investing.com - Investing.com South Africa

May 30, 2025
pulisher
May 30, 2025

Cannabis Stocks To ResearchMay 25th - MarketBeat

May 30, 2025
pulisher
May 30, 2025

Cannabis Stocks To Consider – May 28th - Defense World

May 30, 2025
pulisher
May 29, 2025

Incannex Healthcare Advances RePOSA Trial to Phase 3 - TipRanks

May 29, 2025
pulisher
May 29, 2025

Incannex advances to phase 3 trial for sleep apnea treatment - Investing.com Australia

May 29, 2025
pulisher
May 29, 2025

Incannex Healthcare Advances IHL-42X Reposa Trial To Phase 3 Following FDA Protocol Clearance - marketscreener.com

May 29, 2025
pulisher
May 29, 2025

Breakthrough: FDA Green-Lights Phase 3 Trial for Revolutionary Oral Sleep Apnea Treatment - Stock Titan

May 29, 2025
pulisher
May 29, 2025

Incannex cancels remaining Series A Warrants to reduce dilution By Investing.com - Investing.com South Africa

May 29, 2025
pulisher
May 29, 2025

Promising Cannabis Stocks Worth Watching – May 27th - Defense World

May 29, 2025
pulisher
May 28, 2025

Stonegate Updates Coverage on Incannex Healthcare Inc. (IXHL) 3Q 2025 - BioSpace

May 28, 2025
pulisher
May 28, 2025

Incannex Cancels Series A Warrants to Strengthen Capital - TipRanks

May 28, 2025
pulisher
May 28, 2025

Incannex cancels remaining Series A Warrants to reduce dilution - Investing.com

May 28, 2025
pulisher
May 28, 2025

Incannex Healthcare Inc. Enters Agreement to Cancel Remaining Series A Warrants, Eliminating Up to 347.2 Million Shares from Potential Dilution Ahead of IHL-42X Phase 2 Topline Results - The Manila Times

May 28, 2025
pulisher
May 28, 2025

Incannex Cancels 347M Share Warrant Dilution Before Crucial Sleep Apnea Drug Data Release - Stock Titan

May 28, 2025
pulisher
May 28, 2025

Incannex Healthcare Amends ATM Sales Agreement - TipRanks

May 28, 2025
pulisher
May 28, 2025

SEC Form 424B5 filed by Incannex Healthcare Inc. - Quantisnow

May 28, 2025
pulisher
May 27, 2025

Why E2open Shares Are Trading Higher By 25%; Here Are 20 Stocks Moving Premarket - Benzinga

May 27, 2025
pulisher
May 27, 2025

Cannabis Stocks To Research – May 25th - Defense World

May 27, 2025
pulisher
May 26, 2025

Cannabis Stocks To Follow NowMay 24th - MarketBeat

May 26, 2025
pulisher
May 26, 2025

Cannabis Stocks To Follow Now – May 24th - Defense World

May 26, 2025
pulisher
May 25, 2025

Best Cannabis Stocks To Follow Now – May 23rd - Defense World

May 25, 2025
pulisher
May 24, 2025

Top Cannabis Stocks To Keep An Eye On – May 22nd - Defense World

May 24, 2025
pulisher
May 23, 2025

Best Cannabis Stocks To Watch TodayMay 18th - MarketBeat

May 23, 2025
pulisher
May 22, 2025

Top Cannabis Stocks To Follow Now – May 20th - Defense World

May 22, 2025
pulisher
May 21, 2025

Cannabis Stocks To Follow Today – May 19th - Defense World

May 21, 2025
pulisher
May 21, 2025

Incannex's Big Leap Forward With Obstructive Sleep Apnea Study - Finimize

May 21, 2025

Incannex Healthcare Inc (IXHL) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$13.35
price down icon 0.82%
$8.85
price down icon 0.23%
$125.80
price down icon 0.59%
$286.39
price down icon 1.50%
drug_manufacturers_specialty_generic RDY
$15.31
price up icon 0.53%
$16.97
price up icon 0.12%
자본화:     |  볼륨(24시간):